A New Option for Therapeutic Management of Patients with Cerebrovascular Disease: A Closer Look at the PRoFESS Trial

By Volpe Massimo  

High Blood Pressure & Cardiovascular Prevention, Vol. 15, Iss. 3, 2008-01 ,pp. : 105-107

Adis International

Access to resources Recommend Favorite

A New Therapeutic Option by Subcutaneous Recombinant Hirudin in Patients with Heparin-induced Thrombocytopenia Type II - A Pilot Study

By Huhle G.   Hoffmann U.   Hoffmann I.   Liebe V.   Harenberg J.F.   Heene D.L.  

Thrombosis Research, Vol. 99, Iss. 4, 2000-08 ,pp. : 325-334

Elsevier

Access to resources Recommend Favorite

Recombinant Human Insulin-Like Growth Factor-1: A New Cardiovascular Disease Treatment Option?

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 6, Iss. 4, 2008-01 ,pp. : 258-271

Bentham Science Publishers

Access to resources Recommend Favorite

Adrenomedullins: Therapeutic Potential in Cardiovascular Disease

By  

Current Hypertension Reviews, Vol. 7, Iss. 4, 2011-12 ,pp. : 284-291

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Angiogenesis for Ischemic Cardiovascular Disease

By Freedman S.B.   Isner J.M.  

Journal of Molecular and Cellular Cardiology, Vol. 33, Iss. 3, 2001-03 ,pp. : 379-393

Academic Press

Access to resources Recommend Favorite